Skip to main content

Table 4 Calculated predictive values in different clinical scenarios as reported in the literature

From: Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency

 

Prevalence of Pi*Z positive carriers

NPV

PPV

European Population [4]

1:35

0.029

99.2

49.5

Primary Care in Spain [20]

1:31

0.032

99.1

52.0

Current Study

1:24

0.042

98.9

58.5

COPD II – IV in PFT [34]

1:22

0.046

98.7

61.2

Case finding in Germany [35]

1:30

0.303

89.6

93.4

  1. PFT pulmonary function test, NPV negative predictive value, PPV positive predictive value